East
454 Corp. of Branford, Conn., raised $20 million from 31 accredited investors through a Series C and D preferred stock round of financing. The company, engaged in the business related to discovery and development of instrumentation, reagents and software for DNA sequencing and DNA based analysis and aggregation of data, intends to use the proceeds from the offering for working capital. For more information, call Peter Dacey, vice president, at 203-871-2300.
Adesso Systems Inc. of Waltham, Mass., raised $2.5 million from 36 accredited investors through a private placement of Series B convertible preferred stock and warrants, $1.9 million of the amount raised accounts for conversion of certain promissory notes. The software developer intends to use the proceeds from the offering for debt repayment and working capital. For more information, call John Landry, CEO, at 781-290-5050.
EquipNet Inc. of Braintree, Mass., has filed to raise $1.8 million through a Series B preferred stock round of financing. At the time of its SEC filing, the company had already raised $1.7 million from 34 accredited investors. The provider of online auctions of used industrial equipment and machinery intends to use the proceeds from the offering for debt repayment and working capital. For more information, call Roger Gallo, CEO, at 781-963-6555.
Glass House Technologies Inc. of Framingham, Mass., raised $7.1 million from 13 accredited investors through a Series C preferred stock round of financing. The provider of vendor-neutral services that help clients solve the business problems of data storage intends to use the proceeds from the offering for working capital. For more information, call Mark Shirman, president, at 508-879-5729.
Modular Genetics Inc. of Woburn, Mass., raised $175,000 from two accredited investors through a private placement of convertible promissory notes and common stock warrants. A minimum investment of $25,000 was required on the placement. The company, engaged in genetic research and related product development, intends to use the proceeds from the offering for working capital. For more information, call Kevin Jarrell, executive officer, at 781-376-0020.
Viisage Technology Inc. of Littleton, Mass., raised $15 million from 16 accredited investors through a private placement of common stock. Needham & Co. Inc. and Adams, Harkness & Hill Inc., both of Boston, acted as placement agents for $900,000 in sales commissions. The provider of identity verification solutions intends to use the proceeds from the offering for salaries and fees, purchase, rental or leasing and installation of machinery and equipment, debt repayment and working capital. For more information, call Elliot Mark, vice president, at 978-952-2200.
PharmAthene Inc. of Annapolis, Md., has filed to raise $20 million through a Series A convertible redeemable preferred stock round of financing. At the time of its SEC filing, the company had already raised $15 million from one accredited investor. The biopharmaceutical company intends to use the proceeds from the offering for dividends, debt repayment and working capital. For more information, call David Wright, CEO, at 410-571-8920.
Dirig Software Inc. of Nashua, N.H., has filed to raise $2.6 million through a private offering of Series E convertible preferred stock. At the time of its SEC filing, the company had already raised $1.3 million from six accredited investors. The provider of e-business performance solutions intends to use the proceeds from the offering for debt repayment and working capital. For more information, call Jeremy Davis, CEO, at 603-889-2777.
Nimesa Corp. of Portsmouth, N.H., has filed to raise $500,000 through a private offering of common stock. At the time of its SEC filing, the company had already raised $25,000 from one accredited investor. The company, engaged in the business related to QSR customer self-serve order entry system, intends to use the proceeds from the offering for working capital. For more information, call Larry Mihalchick, CEO, at 603-766-1666.
HydroGlobe Inc. of Hoboken, N.J., raised $1.2 million from 16 accredited investors through a Series A preferred stock round of financing. The minimum investment of $10,000 required on the placement can be waived. The provider of water filtration systems for intends to use the proceeds from the offering for working capital. For more information, call John Schroeder, CEO, at 201-656-2100.
Regeneron Pharmaceuticals Inc. of Tarrytown, N.Y., raised $45 million from one accredited investor through a private placement of common stock. The biopharmaceutical company intends to use the proceeds from the offering for working capital. For more information, call Leonard Schleifer, executive officer, at 914-347-7000.
Stemline Therapeutics Inc. of New York has filed to raise $500,000 through a private placement of common stock. The biopharmaceutical research and development corporation intends to use the proceeds from the offering for salaries and fees, research and development, and working capital. For more information, call Ivan Bergstein, CEO, at 212-833-1111.
TRADOS Inc. of Alexandria, Va., raised $2 million from two accredited investors through a private offering of preferred stock. The software developer intends to use the proceeds from the offering for working capital. For more information, call Dev Ganesan, president, at 703-683-6900.
Back to top
South
Primewire Inc. of Marietta, Ga., has filed to raise $500,000 through a private offering of convertible notes. At the time of its SEC filing, the company had already raised $275,000 from eight accredited investors. The provider of Web-based solutions for employee benefits administration intends to use some proceeds from the offering for working capital. For more information, call James Resor, CFO, at 877-321-4945.
Integrated Security Systems Inc. of Irving, Texas, raised $4 million from two accredited investors through a private placement of common stock. The software developer intends to use the proceeds from the offering for working capital. For more information, call C.A. Rundell Jr., CEO, at 972-444-8280.
RLX Technologies Inc. of The Woodlands, Texas, raised $9.8 million from 10 accredited investors through a private placement of Series C1-A convertible participating preferred stock. The server software and hardware company intends to use the proceeds from the offering for working capital. For more information, call Douglas Erwin, CEO, at 281-863-2114.
Troux Technologies Inc. of Austin, Texas, raised $10 million from eight accredited investors through a Series B preferred stock round of financing. The software developer intends to use the proceeds from the offering for working capital. For more information, call Gerald Weghorst, CEO, at 512-536-6270.
Back to top
Midwest
PS Holdings LLC of Lenexa, Kan., has filed to raise $500,000 through a private offering of convertible debentures. A minimum investment of $25,000 is required on the placement. The provider of online procurement solutions in the automotive repair and salvage industry intends to use the proceeds from the offering for working capital. For more information, call Charles Lukens, president, at 913-599-1600.
MQSoftware Inc. of Minneapolis has filed to raise $5.8 million through a private offering of preferred stock. At the time of its SEC filing, the company had already raised $474,000 from 16 accredited investors. Feltl & Co. of Minneapolis is acting as an agent on the placement for $580,300 in sales commissions. The minimum investment of $24,000 required on the placement can be waived. The software developer intends to use the proceeds from the offering for working capital. For more information, call Gregory Smith, CFO, at 952-345-8600.
Back to top
West
Aarohi Communications Inc. of San Jose, Calif., raised $12 million from four accredited investors through a Series B-1 preferred stock round of financing. The developer of storage networking systems intends to use the proceeds from the offering for working capital. For more information, call Ameesh Divatia, CEO, at 408-434-6064.
Aerogen Inc. of Mountain View, Calif., raised $950,000 from one accredited investor through a private placement of secured convertible debenture and common stock warrant. The company, engaged in the research and development of pulmonary drug delivery products, intends to use the proceeds from the offering for working capital. For more information, call Robert Breuil, CFO, at 650-864-7300.
Pilot Software Acquisition Corp. of Mountain View, Calif., raised $4.9 million from six accredited investors through a Series A preferred stock round of financing. The software developer intends to use the proceeds from the offering for working capital. For more information, call Lawrence De Angelis, executive officer, at 650-230-2830.
AnaMed Inc. of Lake Forest, Calif., raised $2.4 million from 32 accredited investors through a Series A preferred stock round of financing. A minimum investment of $1,000 was required on the placement. The developer of implantable products that correct and maintain vision intends to use the proceeds from the offering for working capital. For more information, call Alok Nigam, president, at 949-707-2740.
CoWare Inc. of San Jose, Calif., raised $13.3 million from one accredited investor through a Series E preferred stock round of financing. The software developer intends to use the proceeds from the offering for working capital. For more information, call Peter Calverley, CFO, at 408-436-4720.
CryoVascular Systems Inc. of Los Gatos, Calif., has filed to raise $15 million through a Series D preferred stock round of financing. At the time of its SEC filing, the company had already raised $10 million from one accredited investor. The developer of therapeutic devices for treatment of vascular diseases intends to use the proceeds from the offering for working capital. For more information, call Jeffrey Gold, executive officer, at 408-376-3675.
Oddpost Inc. of San Francisco raised $1 million through a private placement of convertible promissory note. A minimum investment of $40,000 was required on the placement. The software developer intends to use the proceeds from the offering for working capital. For more information, call Ethan Diamond, president, at 415-989-1702.
Ambrx Inc. of San Diego raised $12.5 million from 13 accredited investors through a Series A preferred stock round of financing. The medical research company intends to use the proceeds from the offering for debt repayment and working capital. For more information, call Troy Wilson, executive officer, at 858-731-3542.
Pixterra Inc. of Menlo Park, Calif., has field to raise $175,000 through a private offering of convertible promissory notes. At the time of its SEC filing, the company had already raised $100,000 from one accredited investor. A minimum investment of $10,000 is required on the placement. The company, engaged in the business related to ink jet polymer chemistry, intends to use the proceeds from the offering for working capital. For more information, call Asutosh Nigam, CEO, at 650-319-4693.
Postini Inc. of Redwood City, Calif., raised $10 million from one accredited investor through a Series D preferred stock round of financing. A minimum investment of $1 million was required on the placement. The provider of email security and management for the enterprise intends to use the proceeds from the offering for working capital. For more information, call Shinya Akamine, president, at 650-216-3540.
Securimetrics Inc. of Martinez, Calif., raised $6.9 million from 45 accredited investors through a Series B preferred stock round of financing. The software developer intends to use the proceeds from the offering for working capital and general corporate purposes. For more information, call James Barringer, director, at 800-557-5549.
Sohoware Inc. of Santa Clara, Calif., raised $2.2 million from 17 accredited investors through a private placement of Series C units consisting of one share of Series C preferred stock and a warrant to purchase three shares of common stock. The networking technology company intends to use the proceeds from the offering for working capital. For more information, call C.T. Wu, president, at 408-565-9888.
SurroMed Inc. of Mountain View, Calif., raised $24 million from two accredited investors through a Series F senior preferred stock round of financing. The therapeutics company, engaged in biomarker enabled drug discovery and development, intends to use the proceeds from the offering for working capital. For more information, call August Moretti, CFO, at 650-230-1961.
Synamem Corp. of Burlingame, Calif., has filed to raise $1.1 million through a Series A-1 preferred stock round of financing. At the time of its SEC filing, the company had already raised $360,883 from four accredited investors. Part of the proceeds accounts for conversion of principal and accrued interest of certain promissory notes and cancellation of indebtedness. The provider of biotechnology services intends to use the proceeds from the offering for working capital. For more information, call John Groves, executive officer, at 650-259-5019.
Quantum Vision Inc. of Mountain View, Calif., raised $562,250 from 27 accredited investors through a private placement of secured convertible promissory notes through a bridge loan round of financing. Additionally, the company placed in Series D preferred stock warrant. The developer of cathode ray tube technology intends to use the proceeds from the offering for working capital. For more information, call Steven Jaffe, CEO, at 650-404-8145.
Virtio Corp. of Campbell, Calif., has filed to raise $1.3 million through a private offering of promissory notes convertible into Series D-1 and D-2 convertible preferred stock. At the time of its SEC filing, the company had already raised $913,037 from 14 accredited investors. The software developer intends to use the proceeds from the offering for working capital. For more information, call Shay Ben-Chorin, executive officer, at 408-341-0844.
High Throughput Genomics Inc. of Tucson, Ariz., has filed to raise $900,000 through a private offering of convertible promissory notes. At the time of its SEC filing, the company had already raised $600,000 from five accredited investors. Additionally, the company has filed to place in preferred stock warrants, which will bring in up to $180,000 if warrants are exercised. The biochemical research corporation intends to use the proceeds from the offering for working capital. For more information, call Kirk Collamer, CFO, at 520-547-2827.
Back to top
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: